Bank of New York Mellon’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-293
| Closed | -$15K | – | 4682 |
|
|
2022
Q1 | $15K | Hold |
293
| – | – | ﹤0.01% | 4628 |
|
|
2021
Q4 | $13K | Hold |
293
| – | – | ﹤0.01% | 4607 |
|
|
2021
Q3 | $19K | Hold |
293
| – | – | ﹤0.01% | 4508 |
|
|
2021
Q2 | $29K | Sell |
293
-1,832
| -86% | -$189K | ﹤0.01% | 4374 |
|
|
2021
Q1 | $271K | Sell |
2,125
-66
| -3% | -$9.76K | ﹤0.01% | 3953 |
|
|
2020
Q4 | $243K | Sell |
2,191
-80
| -4% | -$8.96K | ﹤0.01% | 3909 |
|
|
2020
Q3 | $267K | Buy |
2,271
+8
| +0.4% | +$1.38K | ﹤0.01% | 3760 |
|
|
2020
Q2 | $486K | Buy |
2,263
+212
| +10% | +$50.1K | ﹤0.01% | 3495 |
|
|
2020
Q1 | $462K | Buy |
2,051
+99
| +5% | +$28.2K | ﹤0.01% | 3412 |
|
|
2019
Q4 | $524K | Sell |
1,952
-131
| -6% | -$32.9K | ﹤0.01% | 3568 |
|
|
2019
Q3 | $633K | Sell |
2,083
-148
| -7% | -$45.5K | ﹤0.01% | 3409 |
|
|
2019
Q2 | $739K | Sell |
2,231
-29
| -1% | -$14.7K | ﹤0.01% | 3390 |
|
|
2019
Q1 | $1.42M | Buy |
2,260
+41
| +2% | +$18.7K | ﹤0.01% | 2968 |
|
|
2018
Q4 | $552K | Buy |
2,219
+98
| +5% | +$39K | ﹤0.01% | 3434 |
|
|
2018
Q3 | $985K | Buy |
2,121
+41
| +2% | +$19.9K | ﹤0.01% | 3264 |
|
|
2018
Q2 | $1.13M | Sell |
2,080
-67
| -3% | -$40.2K | ﹤0.01% | 3186 |
|
|
2018
Q1 | $1.23M | Buy |
2,147
+29
| +1% | +$18.3K | ﹤0.01% | 3106 |
|
|
2017
Q4 | $1.36M | Sell |
2,118
-150
| -7% | -$106K | ﹤0.01% | 3069 |
|
|
2017
Q3 | $2.14M | Buy |
2,268
+139
| +7% | +$106K | ﹤0.01% | 2799 |
|
|
2017
Q2 | $1.86M | Sell |
2,129
-1
| -0% | -$819 | ﹤0.01% | 2894 |
|
|
2017
Q1 | $1.47M | Sell |
2,130
-163
| -7% | -$107K | ﹤0.01% | 3040 |
|
|
2016
Q4 | $1.65M | Buy |
2,293
+189
| +9% | +$131K | ﹤0.01% | 2965 |
|
|
2016
Q3 | $1.55M | Sell |
2,104
-118
| -5% | -$95.5K | ﹤0.01% | 2922 |
|
|
2016
Q2 | $1.85M | Sell |
2,222
-63
| -3% | -$58.6K | ﹤0.01% | 2753 |
|
|
2016
Q1 | $1.89M | Sell |
2,285
-37
| -2% | -$29.1K | ﹤0.01% | 2690 |
|
|
2015
Q4 | $2.62M | Sell |
2,322
-18
| -0.8% | -$20.9K | ﹤0.01% | 2558 |
|
|
2015
Q3 | $1.99M | Sell |
2,340
-719
| -24% | -$1.04M | ﹤0.01% | 2749 |
|
|
2015
Q2 | $5.42M | Buy |
3,059
+965
| +46% | +$1.23M | ﹤0.01% | 2303 |
|
|
2015
Q1 | $2.52M | Buy |
2,094
+91
| +5% | +$107K | ﹤0.01% | 2702 |
|
|
2014
Q4 | $2.27M | Buy |
2,003
+194
| +11% | +$199K | ﹤0.01% | 2794 |
|
|
2014
Q3 | $1.82M | Buy |
1,809
+98
| +6% | +$111K | ﹤0.01% | 2940 |
|
|
2014
Q2 | $2.26M | Sell |
1,711
-533
| -24% | -$641K | ﹤0.01% | 2839 |
|
|
2014
Q1 | $3.13M | Buy |
2,244
+84
| +4% | +$109K | ﹤0.01% | 2586 |
|
|
2013
Q4 | $2.48M | Sell |
2,160
-837
| -28% | -$1.15M | ﹤0.01% | 2752 |
|
|
2013
Q3 | $3.76M | Buy |
2,997
+1,290
| +76% | +$876K | ﹤0.01% | 2412 |
|
|
2013
Q2 | $678K | Buy |
+1,707
| New | +$724K | ﹤0.01% | 3377 |
|
Other funds holding RMTI
RB
PCM
AC
VCA
Bank of New York Mellon's RMTI Position: Q2 2022 in Review
Bank of New York Mellon sold out of Rockwell Medical (RMTI) in Q2 2022, closing a stake of 293 shares — an estimated $15K sold.
Bank of New York Mellon first reported a position in RMTI in Q2 2013 and held it in 36 quarters. The position peaked at $5.42M in Q2 2015. 36 funds tracked by Wall St. Rank hold RMTI as of Q2 2022.
- Bank of New York Mellon reported no remaining Rockwell Medical position as of Q2 2022 after selling out during the quarter.
- Bank of New York Mellon sold 293 Rockwell Medical shares in Q2 2022, an estimated $15K.
- Bank of New York Mellon first reported a position in Rockwell Medical in Q2 2013 and held it in 36 quarters.
- Bank of New York Mellon's Rockwell Medical position peaked at $5.42M in Q2 2015.
- 36 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2022.
Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.